
|Videos|April 27, 2022
Studies on LENSAR show evidence that FLACS delivers better outcomes
Author(s)Kassi Filkins
Dr. Sri Ganesh, MBBS, MS, DNB, chairman and managing director of Nethradhama Hospital Pvt. Ltd, discusses his studies on LENSAR and shares his findings.
Advertisement
"The LENSAR platform is very stable, it’s user-friendly, quite accurate and I enjoy using it.”
Dr. Sri Ganesh, MBBS, MS, DNB, chairman and managing director of Nethradhama Hospital Pvt. Ltd, has been using the LENSAR phemto platform for the past several months, performing around 800 cases.
Dr. Ganesh discusses his multiple studies on the system, including comparing different astigmatic outcomes to the previous laser system he was using. In another study he compared femto-assisted cataract surgery versus just phaco, finding significant differences.
"The LENSAR platform is very stable, it’s user-friendly, quite accurate and I enjoy using it.”
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
DSLT for glaucoma and ocular hypertension: Real-world outcomes in 218 eyes
2
ARPA-H funds tear-duct biosensor system for dry eye, systemic disease
3
First patient dosed in phase 3 pivotal cohort of LIGHTHOUSE trial evaluating ATSN-201 for X-linked retinoschisis
4
Memento Medicines launches with $93 million Series A to advance Tie2-activating bispecific for retinal disease
5























